Genes & Cells
Peer-reviewed scientific and practical journal
Editor-in-chief
- Maria A. Lagarkova, Dr. Sci. (Biology), professor
ORCID iD: 0000-0001-9594-1134
Publisher
Founders
- Genes & Cells llc
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
- Eco-Vector
About
“Genes & Cells” (the old name is “Cell Transplantology and Tissue Engineering”) is a quarterly peer-reviewed scientific and practical journal.
The sections of the journal are formulated to fully disclose the target topics of the publication, convey to readers the opinions of leading experts in the field of biomedical technologies on topical issues of concern, acquaint them with the most significant recent foreign and domestic research, materials of thematic conferences, present analytical information on fundamental issues of biomedical technologies trends in the biotech business.
Thus, the journal does not just keep up with the time, but jointly with the website, which is an independent scientific information and analytical mass media, changes the views of representatives of medical specialties on the possibility of using biotechnologies in clinical practice; at the same time, we do not juggle with facts and do not impose subjective unverified data — all the tools of the journal and site are to convey to a wide circle of readers only objective scientific and analytical information.
Journal headings
- expert opinions
- cell technology news
- reviews
- original research
- clinical experience
- discussion and general theoretical work
- stem cell business
Types of manuscript
- reviews
- systematic reviews and metaanalyses
- original research
- clinical case reports and series
- letters to the editor
- short communications
- clinial practice guidelines
Publications
- in English and Russian
- quarterly, 4 issues per year
- continuously in Online First
- distribution in Hybrid model (subscription and in Open Access with Creative Commons CC BY-NC-ND 4.0 license)
Indexation
- SCOPUS
- Russian Science Citation Index
- Russian Science Electronic Library (eLibrary.ru)
- Google Scholar
- Ulrich's Periodicals directory
- WorldCat
- Dimensions
- Crossref
Current Issue



Vol 20, No 2 (2025)
- Year: 2025
- Published: 23.07.2025
- Articles: 7
- URL: https://genescells.ru/2313-1829/issue/view/13468
- DOI: https://doi.org/10.17816/gc.202
Reviews
HMGB1 Protein: Regulation by Specific E3 Ubiquitin Ligases
Abstract
HMGB1 belongs to the high mobility group (HMG) protein family, characterized by the presence of structurally conserved DNA-binding HMGB domain. In addition to two DNA-binding domains connected by a short linker, HMGB1 contains a short N-terminal sequence and an intrinsically disordered C-terminal region. The negatively charged C-terminal HMGB1 domain modulates both DNA–protein and protein–protein interactions. HMGB1 is involved in nearly all major cellular processes, including DNA repair and transcription, and contributes to chromatin organization. Moreover, HMGB1 functions as a damage-associated molecular pattern that initiates inflammatory responses. Given its essential role in maintaining normal cellular functioning, dysregulation of HMGB1 activity is associated with various pathologies, including cancer, cardiovascular diseases, inflammatory conditions, and autoimmune disorders. Therefore, to maintain normal functions, precise regulation of HMGB1 activity is critical and occurs at the levels of gene expression, posttranslational modification, and protein stability. Recent studies have identified specific E3 ubiquitin ligases that promote HMGB1 degradation via the ubiquitin-proteasome pathway. This review summarizes the current knowledge of these enzymes and discusses their functional roles.



Original Study Articles
Optimization of slow freeze protocol for 3D cell structures using brain organoids and chondrospheres as models
Abstract
BACKGROUND: Cryopreservation is a widely used method for long-term viability preservation of cultured cells and complex cellular structures, including organoids, which serve both scientific and clinical purposes, as well as for screening applications. However, data on cryopreservation of organoids derived from differentiated induced pluripotent stem cells (iPSCs) remain limited.
AIM: The work aimed to optimize slow freeze protocols for neural organoids derived from iPSC-differentiated cells and chondrospheres.
METHODS: Neural organoids differentiated from iPSCs were cryopreserved on days 9, 14, 22, 29, and 43 using four different cryopreservation media. Post-thaw assessment included organoid integrity and size measurements, quantitative polymerase chain reaction for MAP2 and NES markers, and immunohistochemical (IHC) staining for βIII-tubulin, MAP2, SOX2, and proliferating cell nuclear antigen (PCNA).
Chondrospheres were derived from human chondrocytes and cryopreserved 29 days after transition to 3D culture conditions in a solution of 82% DMEM + 10% FBS + 8% DMSO + 10 µM ROCK inhibitor Y27632 (Ri, Rho-associated protein kinase inhibitor). Post-thaw IHC analysis was performed to assess the expression of chondrogenic marker proteins, including aggrecan, collagen type II, and SOX9, as well as PCNA.
RESULTS: Neural organoids cryopreserved between weeks 3 and 6 of differentiation retained the highest post-thaw structural integrity. Although organoid diameter decreased by 14.5% on average 1 week after thawing, size was nearly restored to the values observed on the corresponding day of differentiation for organoids not subjected to cryopreservation by week 2. Quantitative polymerase chain reaction and IHC staining confirmed maintenance of neuronal phenotype 2 weeks post-thaw. Chondrospheres showed no change in diameter over 2 weeks post-thaw and exhibited 100% preservation of organoid integrity. IHC analysis confirmed the presence of chondrocytic proteins in chondrospheres 2 weeks after thawing.
CONCLUSION: Based on the study findings, the third week of differentiation was identified as the optimal stage for cryopreservation of iPSC-derived neural organoids. The cryopreservation medium composed of 82% DMEM, 10% FBS, and 8% DMSO was optimal for both neural organoids and chondrospheres.



Modeling the Interaction of Aerosol Particles With Lung Epithelial Cells Using the Lung-On-A-Chip Platform
Abstract
BACKGROUND: The assessment of inhalation toxicity of natural and artificial aerosols and the efficacy of aerosolized drugs is an important practical task. However, in numerous in vitro studies, the test substance is dissolved in a liquid that completely covers the lung tissue cells. For inhalation therapy, this method substantially differs from the physiological scenario of aerosol interaction with the pulmonary epithelium.
AIM: The aim is to develop a platform to study the interaction of inhaled aerosol particles with the pulmonary epithelium on the internal surface of the lung alveoli at the liquid–air interface capable of simulating scenarios of periodic variation of liquid levels during breathing.
METHODS: The A549 human adenocarcinoma cell line was used as a model culture of pulmonary epithelial cells. Cell viability was analyzed using fluorescent microscopy under various exposure conditions at the liquid–air interface and during the deposition of different aerosol particles.
RESULTS: A device has been designed, built, and tested to simulate the internal surface of pulmonary alveoli. It consists of a cell layer located at the air–liquid interface. The cells are cultured on a porous polymer membrane on the surface of a reservoir with culture medium. The hydration level of the cells is controlled by altering the liquid pressure beneath the membrane and recorded by an optical sensor that measures the scattering of laser beam reflected from the surface of the cell layer. The membrane with the cell layer is placed in a chamber allowing to create a directed electric field normal to the aerosol flow passing over the cell layer, which is connected to one electrode. The electric field significantly accelerates the delivery of aerosol particles with an electric charge onto the cell surface. We determined the parameters of static exposure of the model cell monolayer at the air–liquid interface, allowing to maintain high cell viability. The study showed that cyclic variation of cell hydration simulating the respiratory cycle is effective to maintain cell viability for an extended period (60 min). The study showed that doxorubicin nanoaerosol is effective when deposited on the surface of human adenocarcinoma tumor cells located at the liquid–air phase boundary. A model aerosol of a non-toxic substance (glucose) does not have toxic effects under similar conditions.
CONCLUSION: The proposed lung-on-a-chip model is a comprehensive platform to study the inhalation toxicity of natural and artificial aerosols and test the safety and efficacy of aerosolized drugs in situ.



Human cardiomyocytes obtained by directed differentiation of human induced pluripotent stem cells as isoprenaline-based model to evaluate arrhythmogenicity
Abstract
BACKGROUND: Human cardiomyocytes obtained by directed differentiation from induced pluripotent stem cells are a promising model for evaluating arrhythmogenicity and the electrophysiological response to beta-adrenergic stimulation. Isoprenaline is a non-selective beta-adrenergic agonist that is widely used in cardiac electrophysiology studies and clinical practice to treat bradycardia, heart block, and cardiac arrest. However, there is limited quantitative data on its effects on human cardiac ion channels because most studies are conducted on animal models under non-physiological conditions.
AIM: The study aimed to evaluate the effects of isoprenaline on voltage-gated ion channels in human ventricular cardiomyocytes obtained by directed differentiation of human induced pluripotent stem cells from a healthy donor.
METHODS: The patch clamp technique was used to record currents of ion channels, including fast sodium channels, L-type calcium channels, and delayed rectifier potassium channels. Human ventricular cardiomyocytes were obtained by directed differentiation of human induced pluripotent stem cells from a healthy donor.
RESULTS: At a concentration of 1 μM, isoprenaline was found to significantly increase ion channel activity, including an increase in the amplitude of fast sodium currents (73%), L-type calcium currents (120%), and delayed rectifier potassium currents (98%). Additional parameters of electrophysiological activity were also obtained, providing a deeper understanding of a beta-adrenergic response in human cardiomyocytes.
CONCLUSION: Human cardiomyocytes obtained by directed differentiation were assessed as a reliable model to evaluate arrhythmogenicity and responses to beta-adrenergic stimulation. These quantitative data can be used to create mathematical models of cardiac function and predict the behavior of cardiac tissue under sympathetic stimulation.



Collagen-based conjunctival tissue equivalent: in vitro evaluation of biocompatibility and biomechanical properties
Abstract
BACKGROUND: The development of a conjunctival equivalent capable of repairing tissue defects and preventing pathological scarring is a critical goal in biomaterial design for reconstructive procedures, in which collagen is frequently employed. Evaluating the biocompatibility and biomechanical properties of such materials supports the advancement of effective surgical approaches for conjunctival reconstruction.
AIM: The work aimed to evaluate the biocompatibility of human conjunctival epithelial cells (hCECs) with a collagen membrane (CM) developed using an original technique in vitro; to confirm its noncytotoxicity toward hCECs; to characterize hCEC morphology and expression of specific proteins on CM; and to compare the biomechanical properties of CM with native conjunctiva.
METHODS: A primary culture of hCECs was obtained using the explant method and verified through staining for the markers cytokeratin 7 and mucin 5AC. Two CM formulations (collagen concentration 10 mg/mL and 30 mg/mL) were tested. Cytotoxicity of the 30 mg/mL CM was evaluated by seeding hCECs at 50,000 cells/cm2 followed by MTS assay and viability testing with calcein-AM and Hoechst staining. hCECs morphology was analyzed using phase-contrast images of the cell culture after seeding on CM and immunocytochemical staining for cytokeratin 7 and mucin 5AC. Biomechanical properties of the 30 mg/mL CM and conjunctiva were assessed using static and dynamic tests on an indentation machine.
RESULTS: Phase-contrast microscopy revealed that within 1 week after seeding, hCECs migrated into the inner layers of the 10 mg/mL CM, whereas on the 30 mg/mL CM, the cells formed a confluent monolayer on its surface. The metabolic activity assay revealed no significant difference between the control groups and 30 mg/mL CM. In the live/dead assay, 95% of cells in both groups stained positive with calcein. The immunocytochemical profile of hCECs remained unchanged: as in the control group, cells cultured on the CM expressed conjunctiva-specific cytokeratin 7 and mucin 5AC. The Young’s modulus values for the CM and bulbar conjunctiva were comparable: 0.0008739 ± 0.0004332 GPa and 0.0009472 ± 0.001323 GPa, respectively (p = 0.0549). The hardness of the CM was significantly higher than that of the conjunctiva (p < 0.0001), while its viscosity was significantly lower compared to native tissue (p < 0.0001).
CONCLUSION: hCECs remained viable after seeding on the tested CM, confirming its noncytotoxicity. The migration of hCECs into the matrix indicates the material’s ability to create a favorable microenvironment for conjunctival epithelialization and to undergo resorption following cell colonization. Preservation of the molecular profile of hCECs indicates high biocompatibility of the CM with conjunctival epithelium. The 30 mg/mL CM exhibits elasticity comparable to that of conjunctiva, with higher hardness and lower viscosity. Optimization of CM biomechanical properties for specific clinical needs holds promise.



Age-related immunophenotypic characteristics of perivascular mesenchymal stem cells in patients with heart defects
Abstract
BACKGROUND: Currently, there are only a few studies evaluating the role of perivascular mesenchymal stem cells in the pathogenesis of cardiovascular diseases. Heart defects are a broad category of conditions affecting people of all ages. Therefore, biological characteristics of perivascular mesenchymal stem cells may be relevant to this area of research. The expression profile of surface markers is a key characteristic of cells that represents their functional state. This work evaluated and compared immunophenotypic characteristics of perivascular mesenchymal stem cells obtained from patients of different ages with heart defects of various non-inflammatory origins.
AIM: The study aimed to evaluate morphotypes and immunophenotypes of perivascular mesenchymal stem cells in pediatric and elderly patients with heart defects of various origins.
METHODS: The study included 16 patients of various ages with heart defects. Mesenchymal stem cells were isolated from perivascular adipose tissue and cultured. The levels of the following surface markers expressed by these cells were evaluated using flow cytofluorimetry for passages 2–4: CD90, CD105, CD73, CD34, and HLA-DR.
RESULTS: Only 47.97% of the cells in passage 2 in the pediatric group expressed specific surface markers. However, the number of cells showing a perivascular mesenchymal stem cell phenotype increased with each further passage (p = 0.0016). The subcultivation of perivascular mesenchymal stem cells obtained from older patients revealed that, in passage 2, 95.98% of the cells had specific surface markers, which decreased to 44.59% by passage 4 (p = 0.0016).
CONCLUSION: The expression of the study surface markers (CD90, CD105, CD73, CD34, HLA-DR) was less significant in perivascular mesenchymal stem cells obtained from older patients with non-inflammatory heart defects than in cells obtained from children with similar defects.



Pro-regenerative effects of 5-hydroxytryptamine in cultured dermal fibroblasts and subcutaneous adipose tissue-derived mesenchymal stromal cells
Abstract
BACKGROUND: Mesenchymal stem cells of the skin and subcutaneous adipose tissue play a critical role in epithelial regeneration by proliferating and differentiating into skin cells to replace damaged or dead tissue. In addition, they act via autocrine and paracrine signaling to promote tissue repair and wound healing.
AIM: The work aimed to investigate the in vitro effects of serotonin on the regenerative potential—namely, proliferation, migration, and cell death—of dermal fibroblasts (DFs) and subcutaneous adipose tissue-derived mesenchymal stromal cells (SAT-MSCs).
METHODS: Primary DF and SAT-MSC cultures were obtained from Wistar rats and divided into the following groups: DF/SAT-MSCs cultured in standard medium and DF/SAT-MSCs cultured with serotonin supplementation. Cell morphology and proliferation were assessed microscopically using an Axio Vert.A1 microscope (Carl Zeiss, Germany). Cell migration dynamics were studied in a scratch assay. Cell death resulting from apoptosis and/or necrosis was evaluated using fluorescence microscopy with Annexin V-FITC/PI staining (ServiceBio, China).
RESULTS: Both DFs and SAT-MSCs responded to serotonin supplementation in standard culture medium with increased proliferation. Quantification of migrated cells revealed an increase in the conditional migration speed of SAT-MSCs under conditions of serotonin supplementation. Additionally, serotonin-treated cultures demonstrated reduced levels of apoptotic and necrotic cells.
CONCLUSION: Activation of serotonin signaling mechanisms plays an important role in wound healing following various skin and subcutaneous tissue injuries by enhancing cell viability, DF proliferation, and both proliferation and migration of SAT-MSCs, as demonstrated in our study. These findings suggest that serotonin or 5-hydroxytryptamine receptor agonists may serve as promising candidates for promoting skin repair in patients with injuries. Importantly, the cellular response to serotonin signaling is tissue-specific and depends on the receptor subtype and intracellular signaling pathways mediating secondary messenger activation.


